Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pancreatic Juice and Secretion01:26

Pancreatic Juice and Secretion

2.8K
Pancreatic juice is a clear fluid produced by the pancreas, containing water, salts, sodium bicarbonate, and enzymes vital for digestion in the small intestine. It helps break down large molecules, facilitating nutrient absorption.
When acidic chyme from the stomach enters the duodenum, it triggers the release of secretin, a hormone that prompts pancreatic juice secretion. After a fatty meal, cholecystokinin, another hormone, stimulates gallbladder contraction and enhances enzyme-rich...
2.8K
Acute Pancreatitis I: Introduction01:27

Acute Pancreatitis I: Introduction

1.2K
Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
1.2K
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

683
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
683
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

330
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
330
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

780
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
780
Tumor Immunotherapy01:27

Tumor Immunotherapy

1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implications and risk of new versus persisting intraductal papillary mucinous neoplasms after pancreatic surgery: meta-analysis.

BJS open·2026
Same author

How I Use the Fourth Arm in Robotic Pancreatoduodenectomy.

Journal of hepato-biliary-pancreatic sciences·2026
Same author

Availability and Use of Social Determinants of Health Data in Alliance Gastrointestinal Cancer Clinical Trials.

JCO oncology practice·2026
Same author

Postpancreatectomy acute pancreatitis after distal pancreatectomy: tri-institutional international cohort.

BJS open·2026
Same author

A novel classification of small bowel adenocarcinoma based on the hidden genome classifier: a multi-institutional study.

Journal of the National Cancer Institute·2026
Same author

Robotic Transmesocolic Approach to the Left Retroperitoneum.

Annals of surgical oncology·2026

Related Experiment Video

Updated: Jan 22, 2026

Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy
12:04

Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy

Published on: August 14, 2012

29.5K

Pancreatic neuroendocrine tumors.

Giampaolo Perri1, Laura R Prakash, Matthew H G Katz

  • 1Department of Surgical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA.

Current Opinion in Gastroenterology
|July 16, 2019
PubMed
Summary

Pancreatic neuroendocrine tumors (pNETs) are rare and varied. Management depends on grade and stage, with surgery for localized disease and other therapies for advanced cases.

More Related Videos

Establishment and Characterization of Small Bowel Neuroendocrine Tumor Spheroids
09:43

Establishment and Characterization of Small Bowel Neuroendocrine Tumor Spheroids

Published on: October 14, 2019

6.9K
Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma
05:44

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma

Published on: November 5, 2020

5.0K

Related Experiment Videos

Last Updated: Jan 22, 2026

Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy
12:04

Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy

Published on: August 14, 2012

29.5K
Establishment and Characterization of Small Bowel Neuroendocrine Tumor Spheroids
09:43

Establishment and Characterization of Small Bowel Neuroendocrine Tumor Spheroids

Published on: October 14, 2019

6.9K
Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma
05:44

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma

Published on: November 5, 2020

5.0K

Area of Science:

  • Oncology
  • Gastroenterology
  • Endocrinology

Background:

  • Pancreatic neuroendocrine tumors (pNETs) are rare, heterogeneous neoplasms with variable malignant potential.
  • Recent literature updates have revised classification, prognostic criteria, and diagnostic/therapeutic guidelines for pNETs.

Purpose of the Study:

  • To review current understanding and management strategies for pancreatic neuroendocrine tumors.
  • To highlight updated diagnostic and therapeutic guidelines based on recent scientific literature.

Main Methods:

  • Review of current scientific literature on pNETs.
  • Analysis of updated classification, prognostic stratification, and consensus guidelines.
  • Evaluation of diagnostic and therapeutic approaches.

Main Results:

  • Most pNETs are incidentally found on imaging.
  • Tumor grade and stage dictate biologic behavior and treatment.
  • Surgery is curative for localized pNETs; observation may be suitable for small, nonfunctioning G1 tumors.
  • Liver metastases management includes surgery and liver-directed therapies.
  • For unresectable disease, somatostatin analogs, everolimus, PRRT, and chemotherapy prolong survival.

Conclusions:

  • Management of pNETs requires individualized strategies based on tumor characteristics.
  • Surgical resection remains the primary curative option for localized pNETs.
  • Multimodal therapies are crucial for managing advanced or metastatic pNETs, improving patient survival.